Post the two acquisitions, target price updates: CCZ Equities 58c (up from 53c) Cannacord 55c (up from 54c) FY15 EBITDA estimated at $15.7m trading on 12x FY15 EBITDA
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game